Primary lung cancer remains the most common malignancy after non-melanocytic skin
cancer, and deaths from lung cancer exceed those from any other malignancy worldwide [1] …

Substantial progress has been made in cancer screening in China due to the substantial
efforts of all levels of the government. Four large-scale population-based screening …

Background Cancer mortality rates, though not absolute numbers of deaths, have been
decreasing over the last three decades in Europe. Materials and methods We estimated …

1. In KEYNOTE-189, patients with metastatic non-squamous NSCLC, PS 0-1, without
sensitising EGFR or ALK mutations, were randomised to receive pemetrexed and a platinum …

Background Improving survival and extending the longevity of life for all populations
requires timely, robust evidence on local mortality levels and trends. The Global Burden of …

Background We predicted cancer mortality figures in the European Union (EU) for the year
2017 using most recent available data, with a focus on lung cancer. Materials and methods …

We present the largest whole-genome sequencing (WGS) study of non-small cell lung
cancer (NSCLC) to date among 6,004 individuals of Chinese ancestry, coupled with 23,049 …

At the time of cancer diagnosis, body mass index (BMI) is inversely correlated with lung
cancer risk, which may reflect reverse causality and confounding due to smoking behavior …

Screening with low-dose computed tomography of high-risk individuals with a smoking
history reduces lung cancer mortality. Current screening guidelines and eligibility criteria …

Background Lung cancer (LC) is one of the most aggressive, prevalent and fatal
malignancies. Gut microbes and their associated metabolites are thought to cause and …